BCMA polypeptides and uses thereof

Details for Australian Patent Application No. 2005318086 (hide)

Owner Merck Serono SA

Inventors Cledat, Anne-Francoise; Primas, Gwenael; Belloir, Benedicte

Agent Griffith Hack

Pub. Number AU-B-2005318086

PCT Pub. Number WO2006/067210

Priority 04293108.9 23.12.04 EP

Filing date 22 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 7 July 2011

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/067210 Priority application(s): WO2006/067210

30 April 2009 Alteration of Name

  The name of the applicant has been altered to Merck Serono SA

7 July 2011 Application Accepted

  Published as AU-B-2005318086

3 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005318087-Rescue of influenza virus

2005318077-A perfusion assessment method and system based on bolus administration